- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05206344
The Benefit of the Intervention of Clowns in Pediatric Oncology in the Accompaniment of Painful Acts (ICOD)
Study on the Benefit of the Intervention of Clowns in Pediatric Oncology in the Accompaniment of Painful Acts
The diagnosis and treatment of childhood cancer involves frequent and repeated painful acts. The pediatric oncology-hematology service of Nancy's hospital innovates thanks to the involvement of clowns in the hospital. The effects of the clown's intervention corroborate the results of studies which demonstrate that when painful complaints are increased by an empathetic attitude, they are reduced by half when the child is distracted.
The main objective is to assess the impact of the presence or absence of clowns during the performance of a painful act, on pain, in children who have benefited from this act. no clowns during the performance of a painful act, on anxiety, in children who have benefited from this act.
The secondary objectives are:
- Evaluate the impact of the presence or not of clowns during the performance of a painful act, on the anxiety of the parents of the child who benefited from this act.
- Measure the perception and acceptance of the healthcare team of the presence of clowns 1 time every 3 months.
- Measure the clowns' perception of their interaction with the child, the parents and the healthcare team once every 3 months.
- Evaluate the overall impact of the clown intervention during the performance of a painful act in children on the course of the act by a "neutral" person (health manager) once every 3 months.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Valérie GAUZES
- Phone Number: 0383154066
- Email: v.gauzes@chru-nancy.fr
Study Locations
-
-
-
Nancy, France, 54035
- Recruiting
- CHRU de Nancy
-
Contact:
- Valérie Gaüzes
-
Principal Investigator:
- Valérie Gaüzes
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Child virgin with experience for targeted acts during the 1st painful act or child undergoing follow-up provided that he is virgin with experience of the presence of clowns during these acts.
- Child with cancer
- Child requiring a painful act among the following 3 acts: lumbar puncture, myelogram, needle placement in an implantable chamber
- Parental authority holder (s) who have received full information on the organization of the research and who have given their written consent for the participation of their child
- Personal adhesion of the child with a view to his participation
- Presence of at least one of the two parents during act 1
- Availability of the duo of clowns for the realization of act n ° 1 if the group assigned is the group Clowns-Sans Clowns
Exclusion Criteria:
- Parents / child's refusal of clowns to intervene
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Without Clowns - Clowns (WC-C)
Firstly a painful act without the presence of the clown duo, then in a second time the same painful act in the presence of the clown duo
|
presence or absence of clowns during the performance of a painful act, on pain
|
OTHER: Clowns- Without clowns (C-WC)
Firstly a painful act with the presence of the clown duo, then in a seconde time, the same painful act without the presence of the clown duo
|
presence or absence of clowns during the performance of a painful act, on pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Pain score of the patient Self Assessment Scale (VAS)
Time Frame: inclusion, up to 2 years
|
The scale is between 0 to 100
|
inclusion, up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety score of the patient with modified-Yale Preoperative Anxiety Scale (m-YPAS)
Time Frame: inclusion, up to 2 years
|
The scale is between 0 to 100 If the score is inferior to 24, the patient is considered relaxed If the score is superior to 24, the patient is considered anxious
|
inclusion, up to 2 years
|
Anxiety score of the patient with modified-Yale Preoperative Anxiety Scale (m-YPAS)
Time Frame: up to 8 weeks after inclusion
|
The scale is between 0 to 100 If the score is inferior to 24, the patient is considered relaxed If the score is superior to 24, the patient is considered anxious
|
up to 8 weeks after inclusion
|
Usual Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-B)
Time Frame: inclusion, up to 2 years
|
The score is between 21 to 77 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
|
inclusion, up to 2 years
|
Usual Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-B)
Time Frame: up to 8 weeks after inclusion
|
The score is between 21 to 77 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
|
up to 8 weeks after inclusion
|
Change of Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-A)
Time Frame: inclusion, up to 2 years
|
The score is between 20 to 80 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
|
inclusion, up to 2 years
|
Change of Anxiety score of the parents Questionnaire State-Trait Anxiety Inventory (STAI form Y-A)
Time Frame: up to 8 weeks after inclusion
|
The score is between 20 to 80 Score superior to 65 : very high anxiety Score between 56 to 65 : high anxiety Score between 46 to 55 : medium anxiety Score between 36 to 45 : low anxiety Score inferior to 35 : very low anxiety
|
up to 8 weeks after inclusion
|
Score of perception and acceptance of the presence of clowns with the healthcare team Questionnaire
Time Frame: through completion of the study, an average of 2 years
|
The questionnaire is composed by 19 questions The scale of each question is between 1 (not agree at all) to 4 (totally agree)
|
through completion of the study, an average of 2 years
|
Perception score of interactions with the child, parents and the team with clowns Questionnaire
Time Frame: through completion of the study, an average of 2 years
|
The questionnaire is composed by 12 questions The scale of each question is between 1 (not agree at all) to 4 (totally agree)
|
through completion of the study, an average of 2 years
|
Score of evaluation of the overall impact of the presence or not of a clown Questionnaire
Time Frame: through completion of the study, an average of 2 years
|
The observation gris is composed by 14 questions
|
through completion of the study, an average of 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Pascal Chastagner, CHRU de Nancy
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2019-A03302-55
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on clowns
-
University of CoimbraPortuguese Oncology Institute, CoimbraCompletedCancer | Biomarkers | Complementary Therapies | Ambulatory Care | Well-Being, PsychologicalPortugal
-
Meyer Children's HospitalCompleted
-
Hospital San Carlos, MadridTerminated
-
Sheba Medical CenterCompletedPre Operative AnxietyIsrael